Detection of IgE and IgG antibodies in Aspergillosis is of diagnostic significance. The serological methods, such as agglutination, gel diffusion and counter immuno electrophoresis that are commonly used in the laboratories for diagnosis of Aspergillus induced infections, are less sensitive and high cross reactivity is often encountered. We carried out work on characterization and identification of diagnostically relevant antigens of A.
INTRODUCTION
The incidence and mortality due to mycotic infections has been observed to be on the rise in past decade (1) . Pathogens belonging to fungal genus Aspergi//us are most ubiquitous and worldwide in distribution. Aspergillus induced infections are increasingly recognised as emerging threat to the public health. There are four major species of Aspergi/lus namely A.fumigatus, A.flavus, A.niger and A.terreus that cause aspergillosis in humans. However, A.fumigatus is the most prevalent and potential pathogen found in about 90% of Aspergil-/us induced manifestations, The allergic disorders caused by inhalation of A.fumigatus conidia include allergic bronchopulmonary aspergillosis (ABPA) (2), allergic asthma and hypersensitivity pneumonitis (3) . Colonization and saprophytic growth of A.fumigatus in pre-existing pulmonary cavities of diverse origin lead to the development of aspergilloma (4) .In immunocompromised host Author for correspondence Dr G.L. Sharma, at above addrass the infection becomes invasive and disseminates from the primary site of infection to other parts of body including gut, liver, kidney, brain etc. Invasive aspergillosis is reported to be associated with a mortality rate of 55% (5) . Mortality due to Aspergil-, /us infection in bone marrow transplant recipients was observed to be as high as 80% despite appropriate chemotherapy (6) . Cerebral aspergillosis (7) presents symptoms of acute menigitis and is always fatal.
Aspergillosis.patients may be mistaken as patients of tuberculosis and appropriate treatment is missed (8) . Therefore, an early diagnosis of aspergillosis is necessary to prevent irreversible damage caused by A.fumigatus.
SERODIAGNOSIS OF ASPERGILLOSIS
Antigens of A.fumigatus are known to evoke humoral immune responses in the patients of ABPA and aspergilloma (9) (10) . The detection of antibodies against A.fumigatus in these conditions was suggested as an aid forthe diagnosis of aspergillosis (11) . Agglutination,doubleimmunodiffusion (12) and counter immunoelectrophoresis (13) (14) were employed frequently for detection of anti-Aspergillus antibodies. However, methods have remained unsatisfactory because they are tess sensitive and high cross reactivity is often encountered. A number of investigators used enzyme linked immunosorbent assay (ELISA) for detection of IgG and IgE antibodies in the sera of patients of aspergillosis (15) (16) . The antigens used in these studies were diverse obtained either from disrupted mycelia of short term cultures or from different stages of the long term autolytic phase of the growth of A.furnigatus. Variability in the antigens used led to the variations in the results. Due to the absence of precisely defined antigens of A.fumigatus, no WHO reference or international commercial standards were available for specific ELISA for aspergillosis and this restricted the use of ELISA to the R&D laboratories only.
Radioimmunoassay used to analyse patients for antigenimia showed 74% sensitivity and 90% sepcificity. The ELISA was found to be more than 95% sensitive.and specific when used to measure the A.fumigatus antigen in sera or urine. Although antigen detection based methods were considered to hold great promise, these methods have not been established and made available for early diagnosis of aspergillosis.
SPECIFIC ELISA FOR ASPERGILLOSIS
ently healthy oontmlswere-analysed for evaluating kit. In patients, the ELISA OD ranged from 0.25 -2.10, Mean +SD being 0.76 +1:].48. Mean + SD OD in controls was 0.12 + 0.08, range being from 0.026 -0.28 (Fig. 1) . Controls to test ratio 1:3 was considered to be of diagnostic significance. The sensitivity and specificity of the test was found to be 92% and 89% respectively. Links were established with hospitals, research institutes and R&D units of industries to demonsntrate the perfoFmance of test using coded sera. Results were found to be satisfactory. The test is now being used in the laboratory routinely for analysis and diangosis of aspergillosis in patients referred to us by hospitals and clinical centres located in various parts of our country. More than 1400 patients have been screened so far and approximately 18% of them were found to be positive for anti-A.fumigatus antibodies.
It may be difficult to detect antibodies in immunocompromised host with invasive aspergillosis. Therefore, ELISAs for detection of antigenimia (17) (18) and ultrasensitive methods based on luminescent immunoassay have been described (10,19).
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The development of an ideal assay system E~ for diagnosis of aspergillosis was not possible till recently due to anigenic complexity of A.fumigatus 
AN ULTRASENSITIVE LUMINESCENT IMMUNOASSAY (LIA)
The use of LIA for the detection of IgG in biological fluids has been a comparatively recent approach. In this assay system hydrogen peroxide acts on the peroxidase component of conjugate to liberate oxygen radical which intum oxidises luminol to produce aminopthalic acid and nitrogen with simultaneous emission of lightphotons (Fig. 2) . The photons thus produced are then detected by a luminometer. The LIA was evaluated for its potential use in the diagnosis of ABPA. When compared with chromogenic ELISA, the LIA was found to be more sensitive. The LIA could detect up to 0.19 ng of human IgG in the samples. The detectability limit of ELISA was 1.48 ng. The ELISA absorbance or LIA emission of diagnostic significance was obtained at a dilution of 1:400 by ELISA and 1:2400 by LIA in an ABPA patient (Fig. 3) . The analysis of HIV seropositive thalassemic children by ELISA and LIA revealed that the LIA had better discreminatory value (Table 1 ). These observations indicated its possible application in the screening of immunocompromised patients. 
